RL
Ritu Lahkar
About Ritu Lahkar
Data last updated:
Ritu Lahkar is a Director at Chakraborty And Lahkar Innovations Private Limited (since 2023) and Director at Pharmgenerics Sr Private Limited (since 2025). The companies operate in Information Technology. The largest current company by reported revenue is Chakraborty And Lahkar Innovations Private Limited at ₹65,400 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Jan 2023 | 2023 | ₹65,400 (FY 2024) | Active | |
| Director | 19 May 2025 | 2025 | Active |
Board colleagues of Ritu Lahkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suvradeep Chakraborty | 09852132 | Chakraborty And Lahkar Innovations Private Limited | Director |
| Saswati Satarupa Mishra | 10426211 | Pharmgenerics Sr Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ritu Lahkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ritu Lahkar
Ritu Lahkar currently holds 2 directorships: Chakraborty And Lahkar Innovations Private Limited (Director, since 06 Jan 2023, revenue ₹65,400 (FY 2024)); Pharmgenerics Sr Private Limited (Director, since 19 May 2025).
Ritu Lahkar was first appointed on 06 Jan 2023 as Director at Chakraborty And Lahkar Innovations Private Limited. The most recent appointment on record is 19 May 2025 at Pharmgenerics Sr Private Limited.
The current boards of Ritu Lahkar's companies include Suvradeep Chakraborty (Chakraborty And Lahkar Innovations Private Limited), Saswati Satarupa Mishra (Pharmgenerics Sr Private Limited).